Effect of Temperature on Drug Release: Production of 5-FU-Encapsulated Hydroxyapatite-Gelatin Polymer Composites via Spray Drying and Analysis of In Vitro Kinetics

Figure 4

FTIR patterns of (a) the HAp-GEL composites cross-linked with different amounts of GA, pure HAp, and pure GEL; (b) the drug-loaded and unloaded 2% GA HAp-GEL composites, pure 5-FU; and (c) the drug-loaded and unloaded 5% GA HAp-GEL composites, pure 5-FU.

(a)

(b)

(c)